Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Phillip Gottlieb
Introduction
Phillip Gottlieb is a notable inventor based in Buffalo, NY (US). He has made significant contributions to the field of biomedical engineering, particularly in the area of ion channel research. His work focuses on developing innovative solutions for medical challenges, particularly those related to cardiac health.
Latest Patents
Gottlieb holds a patent for a "Mechanically activated channel blocker." This invention discloses a peptide of SEQ ID NO:1 and its variants that effectively blocks stretch-activated ion channels. The peptide, designated as D-GsMTx4, is an enantiomer of a peptide GsMTX-4 found in the venom of a spider. All amino acids in this peptide are D-amino acids. The invention also includes a method for inhibiting stretch-activated ion channels in a cell. This peptide has potential applications in treating cardiac arrhythmias and other pathologies that involve alterations in mechanical stress.
Career Highlights
Gottlieb is affiliated with the State University of New York, where he continues to engage in research and development. His work has garnered attention for its innovative approach to addressing complex medical issues.
Collaborations
He has collaborated with notable colleagues, including Frederick Sachs and Thomas Suchyna, who share his commitment to advancing scientific knowledge and medical technology.
Conclusion
Phillip Gottlieb's contributions to the field of biomedical engineering exemplify the impact of innovative thinking in addressing critical health challenges. His work on the mechanically activated channel blocker highlights the potential for new treatments in cardiac care.